Abbott Laboratories
ABT
113,34 €
Share price
0.04%
Change (1 day)
20.01%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Net assets
Net assets on the balance sheet as of March 2025 : €42.29 Billion
According to Abbott Laboratories's latest financial reports the company has €42.29 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Abbott Laboratories - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $€46.03 B | 31.06% |
| 2023-12-31 | $€35.12 B | 2.09% |
| 2022-12-31 | $€34.40 B | 8.16% |
| 2021-12-31 | $€31.80 B | 18.55% |
| 2020-12-31 | $€26.83 B | -3.97% |
| 2019-12-31 | $€27.94 B | 4.05% |
| 2018-12-31 | $€26.85 B | 3.61% |
| 2017-12-31 | $€25.91 B | 31.59% |
| 2016-12-31 | $€19.69 B | 0.98% |
| 2015-12-31 | $€19.50 B | 9.62% |
| 2014-12-31 | $€17.79 B | -2.75% |
| 2013-12-31 | $€18.29 B | -9.74% |
| 2012-12-31 | $€20.27 B | 7.33% |
| 2011-12-31 | $€18.88 B | 10.35% |
| 2010-12-31 | $€17.11 B | 7.08% |
| 2009-12-31 | $€15.98 B | 27.54% |
| 2008-12-31 | $€12.53 B | 2.92% |
| 2007-12-31 | $€12.17 B | 14.32% |
| 2006-12-31 | $€10.65 B | -12.47% |
| 2005-12-31 | $€12.16 B | 15.23% |
| 2004-12-31 | $€10.56 B | 1.71% |
| 2003-12-31 | $€10.38 B | 1.78% |
| 2002-12-31 | $€10.20 B | -0.55% |
| 2001-12-31 | $€10.25 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | €67.32 B | 59.20% | 🇺🇸 USA |
 Pfizer PFE | €78.12 B | 84.73% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | €42.65 B | 0.86% | 🇺🇸 USA |
 Hologic HOLX | €3.98 B | -90.59% | 🇺🇸 USA |
 Medtronic MDT | €41.59 B | -1.65% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | €15.04 B | -64.44% | 🇺🇸 USA |
 Boston Scientific BSX | €19.34 B | -54.25% | 🇺🇸 USA |
 AstraZeneca AZN | €35.45 B | -16.17% | 🇬🇧 UK |
 Novartis NVS | €33.14 B | -21.63% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | €15.20 B | -64.04% | 🇬🇧 UK |